{"id":"W4296533666","doi":"10.1016/s2152-2650(22)01457-4","title":"MPN-379 Matching-Adjusted Indirect Comparison (MAIC) of Pelabresib (CPI-0610) in Combination With Ruxolitinib vs. JAK Inhibitor Monotherapy in Patients With Intermediate or High-Risk Myelofibrosis","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Phases of clinical research; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001992567,0.001166233,0.002848777,0.0003582626,0.0002336677,0.0008638239,0.001007963,0.001175679,0.005873959],"category_scores_gemma":[0.003260747,0.0006636487,0.005750437,0.000385507,0.0004061785,0.0007950701,0.0008663082,0.002357275,0.0004050728],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001111611,"about_ca_system_score_gemma":0.0009969966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004596324,"about_ca_topic_score_gemma":0.007776658,"domain_scores_codex":[0.9970776,0.001784093,0.0002079011,0.0004216522,0.0001670431,0.0003417573],"domain_scores_gemma":[0.9988623,0.0004762697,0.000278736,0.0001354079,0.00006923298,0.000178082],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.9598513,0.0006012914,0.004964611,0.0008882795,0.02133507,0.00006432323,0.00004121298,0.000911925,0.0007816207,0.0002675267,0.0007311057,0.009561689],"study_design_scores_gemma":[0.6889971,0.1126125,0.08330957,0.0005960176,0.09373989,0.0002831504,0.0002378881,0.01140634,0.001734364,0.002063091,0.004891508,0.0001286072],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762914,0.01524802,0.001007526,0.0004994184,0.001179583,0.0004892849,0.001842081,0.00005723971,0.003385495],"genre_scores_gemma":[0.9963206,0.0009382528,0.000515671,0.000280383,0.0001371465,0.0001941902,0.0005714132,0.000006351206,0.001035912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005873959,"threshold_uncertainty_score":0.01965034,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01947532067221452,"score_gpt":0.2836838542439213,"score_spread":0.2642085335717068,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}